FDA 510(k)
FDA class 2
Substantially Equivalent
🇮🇹 Italy
MTS Gepotidacin 0.016-256 µg/mL
K Number: K260696
·
Decision Apr 17, 2026
Classifications
1
FEI Numbers
9
Registration Numbers
9
Same Product Code
440
Applicant Total
35
Review Days
45
Basic Information
- Device Name
- MTS Gepotidacin 0.016-256 µg/mL
- K Number
- K260696
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.1640
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Liofilchem s.r.l.
- Date Received
- March 3, 2026
- Decision Date
- April 17, 2026
- Product Code
- JWY
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| JWY | Manual Antimicrobial Susceptibility Test Systems | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (JWY), ordered by most recent decision date.
ETEST Gepotidacin (GEP) (0.016-256 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL
FDA 510(k)
FDA Class 2
·Microbiology
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL
FDA 510(k)
FDA Class 2
·Microbiology
The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL
FDA 510(k)
FDA Class 2
·Microbiology
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL
FDA 510(k)
FDA Class 2
·Microbiology
MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD)
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by Liofilchem s.r.l.
| K Number | Device Name | ||
|---|---|---|---|
| K252114 | MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL | Oct 2, 2025 | Substantially Equivalent |
| K251580 | MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD) | Aug 20, 2025 | Substantially Equivalent |
| K243202 | MTS Ceftobiprole 0.002-32 µg/mL | Jan 30, 2025 | Substantially Equivalent |
| K230479 | ComASP Cefiderocol 0.008-128 | May 18, 2023 | Substantially Equivalent |
| K211672 | MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL | Oct 20, 2021 | Substantially Equivalent |
| K200180 | MTS Omadacycline 0.002 - 32 ug/mL | Mar 20, 2020 | Substantially Equivalent |
| K192345 | MTS Ampicillin-Sulbactam 0.016/0.008 - 256/128 µg/mL | Oct 31, 2019 | Substantially Equivalent |
| K191908 | MTS Imipenem 0.016-256 µg/mL | Sep 4, 2019 | Substantially Equivalent |
| K191809 | MTS Imipenem-relebactam 0.002/4-32/4 µg/mL | Aug 23, 2019 | Substantially Equivalent |
| K190914 | MTS Doxycycline 0.016 - 256 µg/mL | May 29, 2019 | Substantially Equivalent |